Pall
-
Pall Corporation Introduces Filter Plates
Pall Corporation has introduced its 96-well filter plate that delivers consistency and reproducibility in applications, such as neonatal screening and multiplexing. The Pall AcroPrep Advance filter plate employs design features that provide uniform f…
Pall | 05 April 2010
-
Pall: Ion Exchange Membrane Capsules
Pall Life Sciences has introduced the Mustang Q XT ion exchange chromatography capsules in a re-usable format. The open-pore structure of the Mustang membrane makes these capsules useful in high flow rate contaminant removal applications and in the c…
Pall | 07 December 2009
-
Pallane Medical Raises Capital for Viral Infections Test
Pallane Medical through its merger with Dia-B Tech, has lodged a prospectus with the Australian Securities Exchange (ASX) and Australian Securities and Investments Commission (ASIC) to raise up to US$15 million. The capital raising is conditional upo…
Pall | 22 June 2009
-
Pall Introduces Depth Filter Capsule System
The Pall Stax single-use depth filter platform helps to reduce labor time and eliminates equipment cleaning expenses and cleaning validation requirements incurred by biopharmaceutical manufacturers with traditional plate and frame depth filtration sy…
Pall | 25 March 2009
-
Pall Life Sciences Introduces Chromatography Sorbents
Pall Life Sciences has introduced chromatography sorbents for processing large amounts of protein during the capture and intermediate steps of purification. The sorbents with Q and S chemistries share the same HyperCel media platform with the com…
Pall | 09 March 2009
-
Pall Introduces Biocontainers
Pall Life Sciences has introduced its line of Allegro3D biocontainers. The product is developed for upstream production and downstream purification applications in the production of biotherapeutic molecules. These applications include cell culture me…
Pall | 23 December 2008
-
Pall Corporation Reports First Quarter Earnings
Pall Corporation has reported sales and earnings for the first quarter ended October 31, 2008. Net earnings were $43.1 million, compared to $36.1 million, an increase of 19.3% over the first quarter of fiscal 2008. Diluted earnings per share (EPS…
Pall | 22 December 2008
-
Pall presents five-year business plan
Pall Corp hosted an investor conference at the Grand Hyatt Hotel in New York City late last month. The company presented its five-year strategic business plan for fiscal 2009 - 2013 to a group of financial analysts. The presentation was also …
Pall | 18 November 2008
-
Pall Corp’s Q4 sales up 11.9%
Pall Corporation’s fourth quarter sales grew to $723.2 million, an 11.9% increase over the fourth quarter of fiscal 2007. Diluted earnings per share (EPS) were $0.57, up from $0.13 a year earlier. Net earnings were $69.9 million, compared t…
Pall | 10 October 2008
-
SGS and Pall Life Sciences Experts Join Pharma Asia’s Editorial Advisory Board
Eize de Boer (PhD), global manager for Life Science Auditing at SGS, and Jerold Martin (MSc), senior vice president, Scientific Affairs for Pall Life Sciences, join Pharma Asia as editorial advisors. Since joining SGS in 2007, Dr. de Boer ha…
Pall | 01 June 2008
